疼痛管理薬市場レポート：薬剤クラス別、適応症別、流通チャネル別、地域別、2025年～2033年

疼痛管理薬の世界市場規模は2024年に714億米ドルに達しました。今後、IMARC Groupは、2033年までに同市場が887億米ドルに達し、2025～2033年の成長率（CAGR）は2.32%になると予測しています。同市場は、慢性疾患の増加、疼痛管理療法の急速な進歩、疼痛管理に対する認識と教育の高まり、政府や規制当局による支援枠組みの導入、効果的な術後疼痛管理に対する需要の高まりなどを背景に、力強い成長を遂げています。

疼痛管理薬の市場分析：

市場の成長と規模慢性疾患の増加、疼痛管理療法の急速な進歩、効果的でより安全な疼痛緩和オプションに対する需要の高まりが、市場の安定成長をもたらしています。

主な市場促進要因：市場成長に影響を与える主な促進要因としては、関節炎やがんの罹患率の上昇、薬剤開発における急速な技術進歩、疼痛管理に対する認識と教育の高まり、政府による支援政策の実施などが挙げられます。

主要市場動向：主な市場動向には、世界のオピオイド危機と、より安全な疼痛管理オプションの必要性から、非オピオイド薬の開発へのシフトが進んでいることが含まれます。さらに、より的を絞った効果的な疼痛管理戦略を提供する個別化医療と薬理ゲノムへの注目が高まっており、市場の成長を後押ししています。

地理的動向：北米は、高度な医療制度、慢性疼痛の高い有病率、代替疼痛管理療法の開発への継続的な取り組みにより市場をリードしています。その他の地域も、ヘルスケアインフラの増加、慢性疾患有病率の上昇、製薬セクターの拡大に後押しされ、大きな伸びを示しています。

競合情勢：市場は、研究開発（R&D）、提携、M&Aなどの戦略的取り組みに積極的に取り組む主要企業の関与によって特徴づけられます。さらに、企業は技術革新に注力し、斬新で効果的な疼痛管理ソリューションを含む製品ポートフォリオの拡充を図っています。

課題と機会：市場は、オピオイド使用における有効性と安全性のバランス、複雑な規制環境への対応など、さまざまな課題に直面しています。しかし、新たな治療領域の開拓や個別化された疼痛管理アプローチへの注目の高まりが、市場成長の新たな機会を生み出しています。

疼痛管理薬の市場動向

慢性疾患の増加

疼痛管理薬の使用を必要とする関節炎、がん、糖尿病、心臓病などの慢性疾患の罹患率が上昇していることは、市場成長を後押しする主要因の1つです。さらに、患者の生活の質を向上させるために疼痛管理薬の利用が増加していることも、成長を促す要因となっています。さらに、変形性関節症や神経障害性疼痛などの慢性疾患に罹患しやすい老年人口が世界中で増加していることも、市場成長を加速させています。これに加えて、肥満や運動不足などの危険因子の増加につながるライフスタイルの変化が、市場の成長を促進しています。さらに、疼痛管理への複合的アプローチを必要とする慢性疾患における疼痛の複雑化が、市場の成長を拡大しています。

疼痛管理療法の急速な進歩

疼痛管理における急速な技術進歩は、生物学的製剤や標的療法を含む、より効果的な新薬の開発につながり、市場成長に明るい展望をもたらしています。これに伴い、従来の疼痛管理薬に伴う副作用を軽減するための治療効果が向上していることも、市場の成長を後押ししています。さらに、製薬業界が研究開発（R&D）に注力するようになり、より優れた疼痛管理プロファイルを持つ薬剤の導入につながっていることも、市場成長に明るい展望をもたらしています。さらに、より的を絞った効果的な疼痛管理戦略を可能にする個別化医療や薬理ゲノミクスの人気が高まっていることも、市場成長の原動力になると予想されます。

疼痛管理に対する意識の高まり

ヘルスケア専門家や患者の間で疼痛管理に対する認識や教育が高まっていることは、市場成長を促進する主要因です。さらに、適切な疼痛管理薬を処方できる医療従事者の理解とトレーニングの高まりも、市場成長に寄与しています。これとともに、患者の間で薬剤の利点や意味合いに関する教育が進み、痛みの治療を求めるようになっていることも、市場の成長を後押ししています。このほか、政府やヘルスケア機関がさまざまな啓発キャンペーンや教育プログラムを実施していることも、成長を促す要因となっています。これに伴い、線維筋痛症や神経因性疼痛のような慢性疼痛疾患の管理に焦点を当てたいくつかのイニシアチブのイントロダクションが導入され、疾患や利用可能な治療オプションに関する認識が高まっていることも、市場成長にプラスの影響を与えています。

政府および規制当局による支援の増加

新薬の開発と承認を支援するさまざまな政府の取り組みや政策が実施されていることは、市場成長にとって明るい見通しとなっています。これに伴い、製薬会社が新たな疼痛管理療法に投資することを奨励する、迅速な承認や希少疾病用医薬品開発に対するインセンティブの導入が、市場の成長を促進すると予想されます。さらに、疼痛管理薬へのアクセスや購入のしやすさに直接影響する、政府が資金を提供するヘルスケアプログラムや償還政策の実施も、市場の成長を大きく後押ししています。さらに、疼痛管理が公衆衛生の重要な要素であることを認識し、十分なサービスを受けていない地域における疼痛管理薬へのアクセスを向上させるプログラムの設立が増加していることも、市場の成長を促進しています。これとともに、新規疼痛管理療法の研究に対する資金提供や助成金のイニシアティブが高まり、技術革新と市場開拓が奨励されていることも、市場成長に弾みをつけています。

外科手術と術後疼痛管理の増加

世界中で外科手術が増加しており、疼痛管理薬の需要を牽引していることが市場成長の原動力となっています。さらに、患者の回復のために術後疼痛管理が広く利用されていることも、市場の成長を後押ししています。このほか、選択的手術や低侵襲（MI）手術の普及が進み、それに伴って効果的な疼痛管理薬の需要が増加していることも、市場成長の原動力になると予想されます。外科手術では急性の疼痛が生じるため、患者の回復を促進し合併症を予防するための疼痛管理が必要となります。これに加えて、効果的な術後疼痛管理は患者の快適性を向上させ、血栓症、肺の問題、慢性疼痛症候群などの術後合併症のリスクを低減します。これとは別に、効果的な疼痛管理戦略の重要性を強調する病院での術後回復促進（ERAS）プロトコルが重視されるようになっていることも、市場に明るい展望をもたらしています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の疼痛管理薬市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場内訳：薬剤クラス別
• 市場内訳：適応症別
• 市場内訳：流通チャネル別
• 市場内訳：地域別
• 市場予測

第6章 市場内訳：薬剤クラス別

• NSAIDs
  • 市場動向
  • 市場予測
• 麻酔薬
  • 市場動向
  • 市場予測
• 抗けいれん薬
  • 市場動向
  • 市場予測
• 片頭痛治療薬
  • 市場動向
  • 市場予測
• 抗うつ薬
  • 市場動向
  • 市場予測
• オピオイド
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第7章 市場内訳：適応症別

• 筋骨格系疼痛
  • 市場動向
  • 市場予測
• 手術と外傷性疼痛
  • 市場動向
  • 市場予測
• がん性疼痛
  • 市場動向
  • 市場予測
• 神経障害性疼痛
  • 市場動向
  • 市場予測
• 片頭痛
  • 市場動向
  • 市場予測
• 産痛
  • 市場動向
  • 市場予測
• 線維筋痛症痛
  • 市場動向
  • 市場予測
• 熱傷痛
  • 市場動向
  • 市場予測
• 歯/顔面痛
  • 市場動向
  • 市場予測
• 小児の疼痛
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第8章 市場内訳：流通チャネル別

• 病院薬局
  • 市場動向
  • 市場予測
• 小売薬局
  • 市場動向
  • 市場予測
• オンライン薬局
  • 市場動向
  • 市場予測

第9章 市場内訳：地域別

• 北米
  • 市場動向
  • 市場予測
• 欧州
  • 市場動向
  • 市場予測
• アジア太平洋地域
  • 市場動向
  • 市場予測
• 中東・アフリカ
  • 市場動向
  • 市場予測
• ラテンアメリカ
  • 市場動向
  • 市場予測

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

• 価格指標
• 価格構造
• マージン分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories, Inc.
  • Pfizer, Inc.
  • Eli Lilly & Company
  • Endo International plc
  • F. Hoffmann-La Roche AG
  • Bausch Health Companies, Inc.
  • Merck & Co. Inc.
  • Allergen Inc.
  • Novartis International AG
  • Johnson & Johnson Private Limited
  • GlaxoSmithKline Plc
  • Purdue Pharma L.P

List of Figures

• Figure 1: Global: Pain Management Drugs Market: Major Drivers and Challenges
• Figure 2: Global: Pain Management Drugs Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Pain Management Drugs Market: Breakup by Drug Class (in %), 2024
• Figure 4: Global: Pain Management Drugs Market: Breakup by Indication (in %), 2024
• Figure 5: Global: Pain Management Drugs Market: Breakup by Distribution Channel (in %), 2024
• Figure 6: Global: Pain Management Drugs Market: Breakup by Region (in %), 2024
• Figure 7: Global: Pain Management Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 8: Global: Pain Management Drugs Industry: SWOT Analysis
• Figure 9: Global: Pain Management Drugs Industry: Value Chain Analysis
• Figure 10: Global: Pain Management Drugs Industry: Porter's Five Forces Analysis
• Figure 11: Global: Pain Management Drugs (NSAIDs) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Pain Management Drugs (NSAIDs) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Pain Management Drugs (Anesthetics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Pain Management Drugs (Anesthetics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Pain Management Drugs (Anticonvulsants) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Pain Management Drugs (Anticonvulsants) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Pain Management Drugs (Antimigraine Agents) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Pain Management Drugs (Antimigraine Agents) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Global: Pain Management Drugs (Antidepressants) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Global: Pain Management Drugs (Antidepressants) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Global: Pain Management Drugs (Opioids) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Global: Pain Management Drugs (Opioids) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Global: Pain Management Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Global: Pain Management Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Global: Pain Management Drugs (Musculoskeletal Pain) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Global: Pain Management Drugs (Musculoskeletal Pain) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Global: Pain Management Drugs (Surgical and Trauma Pain) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: Global: Pain Management Drugs (Surgical and Trauma Pain) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: Global: Pain Management Drugs (Cancer Pain) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: Global: Pain Management Drugs (Cancer Pain) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: Global: Pain Management Drugs (Neuropathic Pain) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: Global: Pain Management Drugs (Neuropathic Pain) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: Global: Pain Management Drugs (Migraine Pain) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: Global: Pain Management Drugs (Migraine Pain) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Global: Pain Management Drugs (Obstetrical Pain) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Global: Pain Management Drugs (Obstetrical Pain) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: Global: Pain Management Drugs (Fibromyalgia Pain) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: Global: Pain Management Drugs (Fibromyalgia Pain) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: Global: Pain Management Drugs (Burn Pain) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: Global: Pain Management Drugs (Burn Pain) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: Global: Pain Management Drugs (Dental/Facial Pain) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: Global: Pain Management Drugs (Dental/Facial Pain) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: Global: Pain Management Drugs (Pediatric Pain) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: Global: Pain Management Drugs (Pediatric Pain) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: Global: Pain Management Drugs (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: Global: Pain Management Drugs (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: Global: Pain Management Drugs Market: Sales through Hospital Pharmacies (in Million USD), 2019 & 2024
• Figure 48: Global: Pain Management Drugs Market Forecast: Sales through Hospital Pharmacies (in Million USD), 2025-2033
• Figure 49: Global: Pain Management Drugs Market: Sales through Retail Pharmacies (in Million USD), 2019 & 2024
• Figure 50: Global: Pain Management Drugs Market Forecast: Sales through Retail Pharmacies (in Million USD), 2025-2033
• Figure 51: Global: Pain Management Drugs Market: Sales through Online Pharmacies (in Million USD), 2019 & 2024
• Figure 52: Global: Pain Management Drugs Market Forecast: Sales through Online Pharmacies (in Million USD), 2025-2033
• Figure 53: North America: Pain Management Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: North America: Pain Management Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Europe: Pain Management Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Europe: Pain Management Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: Asia Pacific: Pain Management Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: Asia Pacific: Pain Management Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: Middle East and Africa: Pain Management Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: Middle East and Africa: Pain Management Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Latin America: Pain Management Drugs Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Latin America: Pain Management Drugs Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

• Table 1: Global: Pain Management Drugs Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Pain Management Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
• Table 3: Global: Pain Management Drugs Market Forecast: Breakup by Indication (in Million USD), 2025-2033
• Table 4: Global: Pain Management Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
• Table 5: Global: Pain Management Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 6: Global: Pain Management Drugs Market Structure
• Table 7: Global: Pain Management Drugs Market: Key Players

The global pain management drugs market size reached USD 71.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 88.7 Billion by 2033, exhibiting a growth rate (CAGR) of 2.32% during 2025-2033. The market is experiencing robust growth driven by the increasing prevalence of chronic diseases, rapid advancements in pain management therapies, heightened awareness and education about pain management, the implementation of supportive government and regulatory frameworks, and the rising demand for effective post-operative pain management.

Pain Management Drugs Market Analysis:

Market Growth and Size: The market is witnessing stable growth, driven by the increasing prevalence of chronic diseases, rapid advancements in pain management therapies, and the growing demand for effective and safer pain relief options.

Major Market Drivers: Key drivers influencing the market growth include the rising incidence of arthritis and cancer, rapid technological advancements in drug development, increasing awareness and education about pain management, and the implementation of supportive government policies.

Key Market Trends: The key market trends involve the ongoing shift towards the development of non-opioid medications, driven by the global opioid crisis and the need for safer pain management options. Additionally, the increasing focus on personalized medicine and pharmacogenomics that offer more targeted and effective pain management strategies, is bolstering the market growth.

Geographical Trends: North America leads the market due to advanced healthcare systems, high prevalence of chronic pain, and ongoing efforts to develop alternative pain management therapies. Other regions are also showing significant growth, fueled by increasing healthcare infrastructure, rising chronic disease prevalence, and expanding pharmaceutical sectors.

Competitive Landscape: The market is characterized by the active involvement of key players who are engaged in strategic initiatives such as research and development (R&D), collaborations, and mergers and acquisitions to enhance their market position. Furthermore, companies are focusing on innovation and expanding their product portfolios to include novel and effective pain management solutions.

Challenges and Opportunities: The market faces various challenges, such as the need for balancing efficacy with safety in opioid use and navigating complex regulatory environments. However, the development of new therapeutic areas, and growing focus on personalized pain management approaches, are creating new opportunities for the market growth.

Pain Management Drugs Market Trends:

Increasing prevalence of chronic diseases

The rising incidence of chronic diseases, such as arthritis, cancer, diabetes, and heart disease, necessitating the use of pain management drugs, is one of the major factors boosting the market growth. Moreover, the increasing utilization of pain management drugs to improve the quality of life of patients, is acting as a growth-inducing factor. Additionally, the growing geriatric population across the globe who are susceptible to chronic conditions, such as osteoarthritis and neuropathic pain, is amplifying the market growth. In addition to this, the rising lifestyle changes, leading to an increase in risk factors, like obesity and physical inactivity, is driving the market growth. Furthermore, the increasing complexity of pain in chronic diseases requiring a multimodal approach to pain management is expanding the market growth.

Rapid advancements in pain management therapies

The rapid technological advancements in pain management, leading to the development of new and more effective drugs, including biologics and targeted therapies, is creating a positive outlook for the market growth. In line with this, the rising improvements in the efficacy of treatments to reduce side effects associated with traditional pain management drugs, is favoring the market growth. Additionally, the increasing focus by the pharmaceutical industry on research and development (R&D), leading to the introduction of drugs with better pain management profiles, is creating a positive outlook for the market growth. Additionally, the rising popularity of personalized medicine and pharmacogenomics that enable more targeted and effective pain management strategies, is anticipated to drive the market growth.

Growing awareness about pain management

The increasing awareness and education about pain management among healthcare professionals and patients is a major factor propelling the market growth. Moreover, the rising understanding and training among healthcare providers who are equipped to prescribe appropriate pain management drugs, is contributing to the market growth. Along with this, the growing education among patients about the benefits and implications of drugs, prompting them to seek treatment for their pain, is boosting the market growth. Besides this, the implementation of various awareness campaigns and educational programs by governments and healthcare organizations is acting as a growth-inducing factor. In line with this, the introduction of several initiatives focusing on the management of chronic pain conditions, like fibromyalgia and neuropathic pain to increase awareness about the conditions and the available treatment options, is positively influencing the market growth.

Rising government and regulatory support

The imposition of various government initiatives and policies that support the development and approval of new drugs is creating a positive outlook for the market growth. In line with this, the introduction of fast-track approvals and incentives for orphan drug development that encourage pharmaceutical companies to invest in new pain management therapies, is anticipated to drive the market growth. Furthermore, the implementation of government-funded healthcare programs and reimbursement policies that directly influence the accessibility and affordability of pain management drugs, is providing a considerable boost to the market growth. Additionally, the growing establishment of programs to increase access to pain management drugs in underserved areas, recognizing pain management as a key component of public health, is fostering the market growth. Along with this, the rising initiatives in funding and grants for research in novel pain management therapies, encouraging innovation and development is providing an impetus to the market growth.

Increasing surgical procedures and post-operative pain management

The rising surgical procedures across the globe, driving the demand for pain management drugs is fueling the market growth. Moreover, the widespread utilization of post-operative pain management for patient recovery is boosting the market growth. Besides this, the increasing prevalence of elective and minimally invasive (MI) surgical procedures, leading to a corresponding rise in the demand for effective pain management drugs is anticipated to drive the market growth. Surgical procedures result in acute pain that requires management to facilitate patient recovery and prevent complications. In addition to this, effective post-operative pain management improves patient comfort and reduces the risk of post-surgical complications such as thrombosis, pulmonary issues, and chronic pain syndromes. Apart from this, the growing emphasis on enhanced recovery after surgery (ERAS) protocols in hospitals, highlighting the importance of effective pain management strategies, is creating a positive outlook for the market.

Pain Management Drugs Industry Segmentation:

Breakup by Drug Class:

• NSAIDs
• Anesthetics
• Anticonvulsants
• Antimigraine Agents
• Antidepressants
• Opioids
• Others

Opioids accounts for the majority of the market share

Breakup by Indication:

• Musculoskeletal Pain
• Surgical and Trauma Pain
• Cancer Pain
• Neuropathic Pain
• Migraine Pain
• Obstetrical Pain
• Fibromyalgia Pain
• Burn Pain
• Dental/Facial Pain
• Pediatric Pain
• Others

Musculoskeletal pain holds the largest share in the industry

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Hospital pharmacies represents the leading market segment

Breakup by Region:

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

North America leads the market, accounting for the largest pain management drugs market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Abbott Laboratories, Inc.
• Pfizer, Inc.
• Eli Lilly & Company
• Endo International plc
• F. Hoffmann-La Roche AG
• Bausch Health Companies, Inc.
• Merck & Co. Inc.
• Allergen Inc.
• Novartis International AG
• Johnson & Johnson Private Limited
• GlaxoSmithKline Plc
• Purdue Pharma L.P.

Key Questions Answered in This Report

• 1.What was the global pain management drugs market size in 2024?
• 2.How will the global pain management drugs market perform over the next five years 2025-2033?
• 3.What is the impact of COVID-19 on the global pain management drugs market?
• 4.What are the key global pain management drugs market drivers?
• 5.What are the major trends in the global pain management drugs market?
• 6.What is the leading drug class in the global pain management drugs market?
• 7.What is the major indication in the global pain management drugs market?
• 8.What is the global pain management drugs market breakup by distribution channel?
• 9.What are the major regions in the global pain management drugs market?
• 10.Who are the leading pain management drug manufacturers?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Pain Management Drugs Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Drug Class
• 5.5 Market Breakup by Indication
• 5.6 Market Breakup by Distribution Channel
• 5.7 Market Breakup by Region
• 5.8 Market Forecast

6 Market Breakup by Drug Class

• 6.1 NSAIDs
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Anesthetics
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Anticonvulsants
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Antimigraine Agents
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Antidepressants
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Opioids
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Others
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast

7 Market Breakup by Indication

• 7.1 Musculoskeletal Pain
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Surgical and Trauma Pain
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Cancer Pain
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Neuropathic Pain
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Migraine Pain
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Obstetrical Pain
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast
• 7.7 Fibromyalgia Pain
  • 7.7.1 Market Trends
  • 7.7.2 Market Forecast
• 7.8 Burn Pain
  • 7.8.1 Market Trends
  • 7.8.2 Market Forecast
• 7.9 Dental/Facial Pain
  • 7.9.1 Market Trends
  • 7.9.2 Market Forecast
• 7.10 Pediatric Pain
  • 7.10.1 Market Trends
  • 7.10.2 Market Forecast
• 7.11 Others
  • 7.11.1 Market Trends
  • 7.11.2 Market Forecast

8 Market Breakup by Distribution Channel

• 8.1 Hospital Pharmacies
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Retail Pharmacies
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Online Pharmacies
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Europe
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Asia Pacific
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Middle East and Africa
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Latin America
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

• 13.1 Price Indicators
• 13.2 Price Structure
• 13.3 Margin Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott Laboratories, Inc.
  • 14.3.2 Pfizer, Inc.
  • 14.3.3 Eli Lilly & Company
  • 14.3.4 Endo International plc
  • 14.3.5 F. Hoffmann-La Roche AG
  • 14.3.6 Bausch Health Companies, Inc.
  • 14.3.7 Merck & Co. Inc.
  • 14.3.8 Allergen Inc.
  • 14.3.9 Novartis International AG
  • 14.3.10 Johnson & Johnson Private Limited
  • 14.3.11 GlaxoSmithKline Plc
  • 14.3.12 Purdue Pharma L.P